Unidad de Investigación, Hospital Universitario de La Princesa, Diego de León 36, 28046 Madrid, Spain.
BMC Cancer. 2011 Mar 9;11:94. doi: 10.1186/1471-2407-11-94.
Lymphoedema is a common and troublesome condition that develops following breast cancer treatment. The aim of this study is to analyze the effectiveness of Manual Lymphatic Drainage in the treatment of postmastectomy lymphoedema in order to reduce the volume of lymphoedema and evaluate the improvement of the concomitant symptomatology.
A randomized, controlled clinical trial in 58 women with post-mastectomy lymphoedema. The control group includes 29 patients with standard treatment (skin care, exercise and compression measures, bandages for one month and, subsequently, compression garments). The experimental group includes 29 patients with standard treatment plus Manual Lymphatic Drainage. The therapy will be administered daily for four weeks and the patient's condition will be assessed one, three and six months after treatment.The primary outcome parameter is volume reduction of the affected arm after treatment, expressed as a percentage. Secondary outcome parameters include: duration of lymphoedema reduction and improvement of the concomitant symptomatology (degree of pain, sensation of swelling and functional limitation in the affected extremity, subjective feeling of being physically less attractive and less feminine, difficulty looking at oneself naked and dissatisfaction with the corporal image).
The results of this study will provide information on the effectiveness of Manual Lymphatic Drainage and its impact on the quality of life and physical limitations of these patients.
ClinicalTrials (NCT): NCT01152099.
淋巴水肿是一种常见且令人困扰的疾病,通常在乳腺癌治疗后发生。本研究旨在分析手法淋巴引流术治疗乳腺癌根治术后淋巴水肿的有效性,以减轻淋巴水肿的体积,并评估伴随症状的改善。
这是一项针对 58 例乳腺癌根治术后淋巴水肿患者的随机、对照临床试验。对照组包括 29 例接受标准治疗(皮肤护理、运动和压迫措施、一个月的绷带,随后是压迫服)的患者。实验组包括 29 例接受标准治疗加手法淋巴引流术的患者。治疗将持续四周,每天进行,在治疗后 1、3 和 6 个月评估患者的病情。主要结局参数是治疗后受累手臂体积减少的百分比。次要结局参数包括:淋巴水肿减轻的持续时间和伴随症状的改善(疼痛程度、肿胀感和受累肢体的功能限制、对身体吸引力和女性气质的主观感觉下降、裸体时的困难和对身体形象的不满)。
本研究的结果将提供有关手法淋巴引流术的有效性及其对这些患者生活质量和身体限制的影响的信息。
ClinicalTrials(NCT):NCT01152099。